国际检验医学杂志
國際檢驗醫學雜誌
국제검험의학잡지
INTERNATIONAL JOURNAL OF LABORATORY MEDICINE
2014年
9期
1143-1144,1163
,共3页
革兰阳性球菌%鲍氏不动杆菌%抗菌药%抗药性 ,细菌%替加环素
革蘭暘性毬菌%鮑氏不動桿菌%抗菌藥%抗藥性 ,細菌%替加環素
혁란양성구균%포씨불동간균%항균약%항약성 ,세균%체가배소
Gram-positive cocci%Acinetobacter baumannii%anti-bacterial agents%drug resistance,bacterial%tigecycline
目的:了解革兰阳性球菌和鲍氏不动杆菌对替加环素及常用抗菌药的耐药状况。方法收集445株革兰阳性球菌及83株鲍氏不动杆菌,采用VITEK 2 Compact全自动微生物鉴定及药敏分析系统对革兰阳性球菌和鲍氏不动杆菌进行鉴定,采用微量肉汤稀释法微生物敏感性试验(M IC法)及纸片扩散抗菌试验(K-B )法检测二者对替加环素及常用抗菌药的敏感性。结果445例革兰阳性球菌中发现金黄色葡萄球菌155例(34.8%),屎肠球菌78例(17.5%),溶血葡萄球菌56例(12.6%),表皮葡萄球菌45例(10.1%),粪肠球菌43例(9.7%),人葡萄球菌18例(4.1%),沃氏葡萄球菌16例(3.6%),鸟肠球菌8例(1.8%)及其他菌株26例(5.8%)。葡萄球菌对青霉素的耐药率达92.4%;对红霉素、克林霉素、苯唑西林、环丙沙星的耐药率超过50%。肠球菌对多种药物存在天然耐药,但对利奈唑胺、替加环素敏感。MIC法检测多重耐药及泛耐药鲍氏不动杆菌对替加环素的敏感率、中介率、耐药率分别为57.1%(47/83)、42.9%(36/83)及0.0%(0/83),K-B法检测分别为2.4%(2/83)、40.5%(34/83)、57.1%(47/83)。结论替加环素对革兰阳性球菌及鲍氏不动杆菌有较好的抗菌活性。
目的:瞭解革蘭暘性毬菌和鮑氏不動桿菌對替加環素及常用抗菌藥的耐藥狀況。方法收集445株革蘭暘性毬菌及83株鮑氏不動桿菌,採用VITEK 2 Compact全自動微生物鑒定及藥敏分析繫統對革蘭暘性毬菌和鮑氏不動桿菌進行鑒定,採用微量肉湯稀釋法微生物敏感性試驗(M IC法)及紙片擴散抗菌試驗(K-B )法檢測二者對替加環素及常用抗菌藥的敏感性。結果445例革蘭暘性毬菌中髮現金黃色葡萄毬菌155例(34.8%),屎腸毬菌78例(17.5%),溶血葡萄毬菌56例(12.6%),錶皮葡萄毬菌45例(10.1%),糞腸毬菌43例(9.7%),人葡萄毬菌18例(4.1%),沃氏葡萄毬菌16例(3.6%),鳥腸毬菌8例(1.8%)及其他菌株26例(5.8%)。葡萄毬菌對青黴素的耐藥率達92.4%;對紅黴素、剋林黴素、苯唑西林、環丙沙星的耐藥率超過50%。腸毬菌對多種藥物存在天然耐藥,但對利奈唑胺、替加環素敏感。MIC法檢測多重耐藥及汎耐藥鮑氏不動桿菌對替加環素的敏感率、中介率、耐藥率分彆為57.1%(47/83)、42.9%(36/83)及0.0%(0/83),K-B法檢測分彆為2.4%(2/83)、40.5%(34/83)、57.1%(47/83)。結論替加環素對革蘭暘性毬菌及鮑氏不動桿菌有較好的抗菌活性。
목적:료해혁란양성구균화포씨불동간균대체가배소급상용항균약적내약상황。방법수집445주혁란양성구균급83주포씨불동간균,채용VITEK 2 Compact전자동미생물감정급약민분석계통대혁란양성구균화포씨불동간균진행감정,채용미량육탕희석법미생물민감성시험(M IC법)급지편확산항균시험(K-B )법검측이자대체가배소급상용항균약적민감성。결과445례혁란양성구균중발현금황색포도구균155례(34.8%),시장구균78례(17.5%),용혈포도구균56례(12.6%),표피포도구균45례(10.1%),분장구균43례(9.7%),인포도구균18례(4.1%),옥씨포도구균16례(3.6%),조장구균8례(1.8%)급기타균주26례(5.8%)。포도구균대청매소적내약솔체92.4%;대홍매소、극림매소、분서서림、배병사성적내약솔초과50%。장구균대다충약물존재천연내약,단대리내서알、체가배소민감。MIC법검측다중내약급범내약포씨불동간균대체가배소적민감솔、중개솔、내약솔분별위57.1%(47/83)、42.9%(36/83)급0.0%(0/83),K-B법검측분별위2.4%(2/83)、40.5%(34/83)、57.1%(47/83)。결론체가배소대혁란양성구균급포씨불동간균유교호적항균활성。
Objective To understand tigecycline and commonly used anti-bacterial agents resistance in Gram-positive cocci and Acinetobacter baumannii .Methods 445 strains of Gram-positive cocci and 83 strains of Acinetobacter baumannii were collected . VITEK 2 Compact automated bacterial identification and susceptibility analysis system was employed to identify Gram-positive coc-ci and Acinetobacter baumannii and their bacterial sensitivities toward tigecycline and commonly used anti-bacterial agents were de-tected by broth microdilution method for antimicrobial susceptibility testing (MIC assay) and Kirby-Bauer disk diffusion susceptibil-ity test(K-B) ,respectively .Results 155(34 .8% ) strains of Staphylococcus aureus ,78(17 .5% ) Enterococcus feces ,56(12 .6% ) Staphylococcus haemolyticus ,45(10 .1% ) Staphylococcus epidermidis ,43(9 .7% ) Enterococcus faecalis ,18(4 .1% ) human Staphy-lococcus ,16(3 .6% ) Wolfowitz Staphylococcus ,8(1 .8% ) birds Enterococci and 26(5 .8% )other strains were found in 445 cases of Gram-positive cocci .The rate of penicillin-resistant Staphylococci was 92 .4% and the rates of Staphylococci′s resistance to eryth-romycin ,clindamycin ,oxacillin and ciprofloxacin were all over 50% .Enterococci ,which was sensitive to linezolid and tigecycline ,was resistant naturally to many drugs .The tigecycline sensitive rate ,intermediate rate and resistance rate acquired by MIC assay for multi-drug resistant and pan-resistant Acinetobacter baumannii were 57 .1% (47/83) ,42 .9% (36/83) and 0 .0% (0/83) ,respec-tively ,while those by K-B methods were 2 .4% (2/83) ,40 .5% (34/83) and 57 .1% (47/83) ,respectively .Conclusion Tigecycline showes good antibacterial activity toward Gram -positive cocci and Acinetobacter baumannii .